LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Drug Safety Update › 22 Jan 2024
Drug Safety Update

Omega

Published on 22 Jan 2024 · source: MHRA — Medicines and Healthcare products Regulatory Agency
Systematic reviews and meta-analyses of randomised controlled trials have highlighted a dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or car…
Drug Safety Update on GOV.UK ↗ All events: Omega

What this means

Drug Safety Update is the MHRA bulletin for healthcare professionals: new safety information, restrictions of use and recommendations for monitoring.

Summary

Systematic reviews and meta-analyses of randomised controlled trials have highlighted a dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors treated with omega-3-acid ethyl ester medicines compared to placebo.

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.